27 Jan 2022 --- DFE Pharma is expanding its nutraceutical portfolio with the launch of three starch-based excipients. The products aim to tap into formulation needs across industry, which has seen heightened attention from consumers since the onset of the COVID-19 pandemic, the company says.
